Literature DB >> 29514388

iRoot FM exerts an antibacterial effect on Porphyromonas endodontalis and improves the properties of stem cells from the apical papilla.

J Bi1,2, Y Liu1,2, X M Liu1,2, L M Jiang1,2, X Chen1,2.   

Abstract

AIM: To investigate the antibacterial activity of a novel intracanal medicament, iRoot FM, against Porphyromonas endodontalis and its effects on the proliferation and osteo-/odontogenic differentiation of stem cells from apical papilla (SCAP).
METHODOLOGY: The agar diffusion test was used to compare the antimicrobial efficacy of iRoot FM with two traditional intracanal medicaments, calcium hydroxide [Ca(OH)2 ] and triple antibiotic paste (TAP). The CCK-8 assay was used to assess the proliferation rate of SCAP when exposed to the three intracanal medicaments. The expression levels of ALP and DMP-1 and the capacity to form mineralized nodules were used to evaluate the osteo-/odontogenic differentiation of SCAP, as assessed by real-time PCR, Western blotting and alizarin red S staining. Data were statistically analysed with one-way analysis of variance (anova), and comparisons between each of two groups were analysed by the least significance difference method. P values less than 0.05 were considered statistically significant.
RESULTS: The zone of inhibition against P. endodontalis produced by iRoot FM was 20.74 ± 4.35 mm, whilst the zones of inhibition of Ca(OH)2 and TAP were 24.89 ± 3.84 mm and 34.51 ± 1.20 mm. The antibacterial capacity of iRoot FM was similar to that of Ca(OH)2 (P > 0.05). SCAP, cultured in conditioned medium with iRoot FM, was associated with greater proliferation and osteo-/odontogenic differentiation capacity than those cultured in conditioned medium with Ca(OH)2 and TAP (P < 0.05). Moreover, iRoot FM had no negative effects on the proliferation rate of SCAP.
CONCLUSIONS: iRoot FM exhibited excellent antibacterial activity against P. endodontalis and could improve the proliferation and differentiation of SCAP. The findings provide evidence that iRoot FM has potential as an intracanal medicament for endodontic procedures in immature permanent teeth.
© 2018 International Endodontic Journal. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Porphyromonas endodontaliszzm321990; antibacterial activity; iRoot FM; osteo-/odontogenic differentiation; proliferation; stem cells from apical papilla

Mesh:

Substances:

Year:  2018        PMID: 29514388     DOI: 10.1111/iej.12923

Source DB:  PubMed          Journal:  Int Endod J        ISSN: 0143-2885            Impact factor:   5.264


  5 in total

Review 1.  Sinking Our Teeth in Getting Dental Stem Cells to Clinics for Bone Regeneration.

Authors:  Sarah Hani Shoushrah; Janis Lisa Transfeld; Christian Horst Tonk; Dominik Büchner; Steffen Witzleben; Martin A Sieber; Margit Schulze; Edda Tobiasch
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

Review 2.  In vitro biocompatibility and bioactivity of calcium silicate‑based bioceramics in endodontics (Review).

Authors:  Wencheng Song; Shue Li; Qingming Tang; Lili Chen; Zhenglin Yuan
Journal:  Int J Mol Med       Date:  2021-05-20       Impact factor: 4.101

3.  In vitro bioactivity of AH plus with the addition of nano-magnesium hydroxide.

Authors:  Xiujuan Sun; Aoteng Sun; Xingya Jia; Shi Jin; Dan Zhang; Keshen Xiao; Qiang Wang
Journal:  Ann Transl Med       Date:  2020-03

Review 4.  Regenerative Endodontics and Minimally Invasive Dentistry: Intertwining Paths Crossing Over Into Clinical Translation.

Authors:  Hisham Elnawam; Menatallah Abdelmougod; Ahmed Mobarak; Mai Hussein; Hamdy Aboualmakarem; Michael Girgis; Rania El Backly
Journal:  Front Bioeng Biotechnol       Date:  2022-02-08

Review 5.  Viability and Stimulation of Human Stem Cells from the Apical Papilla (hSCAPs) Induced by Silicate-Based Materials for Their Potential Use in Regenerative Endodontics: A Systematic Review.

Authors:  José Luis Sanz; Leopoldo Forner; Alicia Almudéver; Julia Guerrero-Gironés; Carmen Llena
Journal:  Materials (Basel)       Date:  2020-02-21       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.